Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001415889-25-016296

Options or other derivatives

  • Director acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hemrajani Rekha Director 2025-06-05 Grant or award · Stock Option (Right to Buy) +22,000 22,000 D: show line 1 in the form
Loading xslF345X05/form4-06092025_080617.xml…